11 – 20 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
2008) 8th Congress of the European-Association-for-Neuro-Oncology (EANO) In Neuro-Oncology 10(6). p.1107-1107(
- Contribution to journal › Published meeting abstract
-
Mark
Survival of rats with N29 brain tumours after irradiation with 5 or 15 Gy and immunization with IFN-gamma secreting tumour cells
2008) 1st International Conference on Biomedical Engineering and Informatics In BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008 2. p.243-247(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Exposure to radiation from global system for mobile communications at 1,800 MHz significantly changes gene expression in rat hippocampus and cortex
(
- Contribution to journal › Article
- 2007
-
Mark
Neuroblastomas and medulloblastomas exhibit more Coxsackie adenovirus receptor expression than gliomas and other brain tumors.
(
- Contribution to journal › Article
-
Mark
Glioma stem cells: Evidence and limitation.
(
- Contribution to journal › Scientific review
-
Mark
Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
(
- Contribution to journal › Article
-
Mark
Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability.
(
- Contribution to journal › Article
-
Mark
Low dose Zebularine treatment enhances immunogenicity of tumor cells
(
- Contribution to journal › Article
- 2006
-
Mark
Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression.
(
- Contribution to journal › Article
-
Mark
Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma
(
- Contribution to journal › Article